Showing results (991-1000 of 1,095) with videos related to

Sort By:
Pageof 110
The New England Journal of Medicine|October 4, 2018
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung CancerLuis Paz-Ares, Alexander Luft, David Vicente, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2024
RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLCKazuhiko Nakagawa, Edward B Garon, Takashi Seto, et al.
Cancer Discovery|June 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathwayPietro Scaparone, Alessia Mira, Taek-Chin Cheong, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 24, 2022
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesotheliomaIris Chiara Salaroglio, Dimas Carolina Belisario, Paolo Bironzo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 13, 2019
Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural MesotheliomaIris C Salaroglio, Joanna Kopecka, Francesca Napoli, et al.
The Lancet. Oncology|May 17, 2014
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trialVanesa Gregorc, Silvia Novello, Chiara Lazzari, et al.
Lung Cancer (Amsterdam, Netherlands)|September 20, 2024
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutationDavid M Waterhouse, Sacha Rothschild, Christophe Dooms, et al.
Biomedicines|January 21, 2023
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center ExperienceIrene Persano, Massimiliano Cani, Benedetta Del Rio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2023
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung CancerCharles M Rudin, Stephen V Liu, Ross A Soo, et al.
Autophagy|November 6, 2021
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functionsSonia Brun, Eloïne Bestion, Eric Raymond, et al.
Pageof 110